优化MRI靶向与系统穿刺策略:在仅有外周带可疑病灶时豁免移行带取样
本研究纳入863例仅有外周带mpMRI可疑病灶且移行带阴性的患者,回顾性比较外周靶向穿刺联合含移行带取样的扩大系统穿刺(A)与不含移行带取样的系统穿刺(B)对临床显著前列腺癌(csPCa)的检出率。结果显示两种方案csPCa检出率相似(48% vs 47%),移行带系统取样仅额外检出2.0%的csPCa,提示可豁免移行带取样以减少穿刺相关并发症。
要点
- 仅外周带mpMRI可疑灶且移行带阴性时,豁免移行带系统取样不影响csPCa检出。
- 移行带系统取样仅额外检出2.0%的csPCa,收益有限。
- 该区域依赖性穿刺策略需前瞻性研究验证以优化系统穿刺范围。
核心结论
- 在外周带靶向穿刺基础上,省略移行带系统取样与标准扩大方案csPCa检出率相似,且可能降低穿刺相关并发症。
研究设计与样本
- 回顾性头对头比较研究,从1685例接受扩大系统穿刺(含移行带取样)及靶向穿刺的患者中,选取863例仅有外周带PCa可疑病灶且移行带mpMRI阴性的患者。
主要发现
- 方案A(外周靶向+含移行带取样的扩大系统穿刺)与方案B(外周靶向+不含移行带取样的系统穿刺)的csPCa检出率分别为48%与47%。
- GS 3+3前列腺癌检出率分别为21%与20%。
- 移行带系统取样仅额外检出2.0%的csPCa。
- 多变量logistic回归模型证实mpMRI病灶的前列腺内带区分布独立影响移行带系统取样的csPCa检出率。
关键数值与推荐
- 临床显著前列腺癌(csPCa)定义为Gleason评分≥3+4。
临床怎么用
- 对于仅有外周带mpMRI可疑病灶且移行带阴性的患者,可考虑在外周靶向穿刺基础上省略移行带系统取样,以减少穿刺相关并发症。
局限性
- 回顾性研究设计,结果需前瞻性评估验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessed whether sampling of the transitional zone can be spared in patients with exclusively peripheral prostate cancer (PCa)-suspicious multiparametric magnetic resonance imaging (mpMRI) lesions who undergo combined mpMRI targeted (TBx) and systematic prostate biopsies (SBx). MATERIALS AND METHODS: Of 1,685 patients who underwent extended SBx including transitional zone sampling and had TBx of ≥1 lesion in the peripheral and/or transitional zone, we selected 863 patients with exclusively peripheral PCa-suspicious lesions and negative transitional zone mpMRI. Clinically significant PCa (csPCa) was defined as Gleason score (GS) ≥3+4. Within the selected cohort we performed a retrospective head-to-head comparison of csPCa detection rates between biopsy protocols: A) combination of peripheral TBx plus extended SBx including transitional zone sampling vs B) peripheral TBx plus SBx without any transitional zone sampling. Analyses were complemented with multivariable logistic regression models (LRMs) in the total cohort for predicting csPCa in SBx transitional zone sampling. RESULTS: Compared to the extended protocol (A), omission of systematic transitional zone sampling (B) yielded similar PCa detection for csPCa (48% vs 47%) and GS 3+3 (21% vs 20%). Only 2.0% csPCa was additionally detected with transitional zone SBx sampling (A). LRM confirmed that intraprostatic zonal distribution of mpMRI lesions independently influences csPCa detection rates of transitional zone SBx sampling. CONCLUSIONS: A peripheral TBx plus SBx without any transitional zone sampling protocol (B) yields similar csPCa detection rates as the standard extended protocol (A) but may reduce biopsy-related morbidity. This zone-dependent biopsy strategy warrants prospective evaluation to optimize the extent of systematic biopsies in presence of suspicious mpMRI lesions.
引用
- Kachanov M, Leyh-Bannurah SR, Roberts MJ, et al. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions. J Urol. 2021. PMID: 34555925. doi:10.1097/JU.0000000000002248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。